Audit of care of acute inflammatory polyradiculoneuropathy in Italy

E. Beghi, A. Bono, G. Bogliun, F. Cornelio, N. Rizzuto, P. Tonali, D. Zerbi, C. Castelli, G. Ferrari, M. Marconi, P. Simone, F. Apollo, L. Amoruso, C. Angelini, C. Briani, E. Fincati, R. Affuso, E. Bottacchi, C. Lia

Research output: Contribution to journalArticle

Abstract

A multicentre prospective investigation of the main treatment regimens for the Guillain-Barre syndrome (GBS) was started in Italy to assess the quality of the care delivered for GBS in clinical practice. Between 14 April 1988 and 31 December 1993, 250 patients (157 males and 93 females aged 3 to 86 years) were recruited in 14 centres. The commonest treatments were plasma exchange (PE) (62 per cent), steroids (ST) (37 per cent) and immunoglobulins (IG) (19 per cent). Eighteen per cent of cases received ST and PE. These data contrast in part with reports on the treatment of GBS published between 1976 and 1993, which showed PE as an effective treatment, IG as a promising but still experimental drug, and ST as a failing therapeutic approach. The variables which seemed to affect the treatment choices most were centre, year of diagnosis, and disease severity. According to this survey, the treatment of GBS in Italy tends only partly to reflect the indications and recommendations in the main scientific reports. This not only indicates a suboptimal impact of the best available knowledge on the treatment of GBS, but also documents the need for more definite guidelines and further research through clinical trials.

Original languageEnglish
Pages (from-to)137-146
Number of pages10
JournalPharmacoepidemiology and Drug Safety
Volume4
Issue number3
DOIs
Publication statusPublished - 1995

Fingerprint

Guillain-Barre Syndrome
Italy
Plasma Exchange
Steroids
Therapeutics
Immunoglobulins
Quality of Health Care
Clinical Trials
Guidelines
Research

Keywords

  • Acute polyneuritis
  • Audit
  • Guillain-Barre syndrome
  • Immunoglobulins
  • Pharmacoepidemiology
  • Plasma exchange
  • Steroids
  • Therapy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Beghi, E., Bono, A., Bogliun, G., Cornelio, F., Rizzuto, N., Tonali, P., ... Lia, C. (1995). Audit of care of acute inflammatory polyradiculoneuropathy in Italy. Pharmacoepidemiology and Drug Safety, 4(3), 137-146. https://doi.org/10.1002/pds.2630040306

Audit of care of acute inflammatory polyradiculoneuropathy in Italy. / Beghi, E.; Bono, A.; Bogliun, G.; Cornelio, F.; Rizzuto, N.; Tonali, P.; Zerbi, D.; Castelli, C.; Ferrari, G.; Marconi, M.; Simone, P.; Apollo, F.; Amoruso, L.; Angelini, C.; Briani, C.; Fincati, E.; Affuso, R.; Bottacchi, E.; Lia, C.

In: Pharmacoepidemiology and Drug Safety, Vol. 4, No. 3, 1995, p. 137-146.

Research output: Contribution to journalArticle

Beghi, E, Bono, A, Bogliun, G, Cornelio, F, Rizzuto, N, Tonali, P, Zerbi, D, Castelli, C, Ferrari, G, Marconi, M, Simone, P, Apollo, F, Amoruso, L, Angelini, C, Briani, C, Fincati, E, Affuso, R, Bottacchi, E & Lia, C 1995, 'Audit of care of acute inflammatory polyradiculoneuropathy in Italy', Pharmacoepidemiology and Drug Safety, vol. 4, no. 3, pp. 137-146. https://doi.org/10.1002/pds.2630040306
Beghi, E. ; Bono, A. ; Bogliun, G. ; Cornelio, F. ; Rizzuto, N. ; Tonali, P. ; Zerbi, D. ; Castelli, C. ; Ferrari, G. ; Marconi, M. ; Simone, P. ; Apollo, F. ; Amoruso, L. ; Angelini, C. ; Briani, C. ; Fincati, E. ; Affuso, R. ; Bottacchi, E. ; Lia, C. / Audit of care of acute inflammatory polyradiculoneuropathy in Italy. In: Pharmacoepidemiology and Drug Safety. 1995 ; Vol. 4, No. 3. pp. 137-146.
@article{9b013a9dc66449a2ad5d69090e9256ff,
title = "Audit of care of acute inflammatory polyradiculoneuropathy in Italy",
abstract = "A multicentre prospective investigation of the main treatment regimens for the Guillain-Barre syndrome (GBS) was started in Italy to assess the quality of the care delivered for GBS in clinical practice. Between 14 April 1988 and 31 December 1993, 250 patients (157 males and 93 females aged 3 to 86 years) were recruited in 14 centres. The commonest treatments were plasma exchange (PE) (62 per cent), steroids (ST) (37 per cent) and immunoglobulins (IG) (19 per cent). Eighteen per cent of cases received ST and PE. These data contrast in part with reports on the treatment of GBS published between 1976 and 1993, which showed PE as an effective treatment, IG as a promising but still experimental drug, and ST as a failing therapeutic approach. The variables which seemed to affect the treatment choices most were centre, year of diagnosis, and disease severity. According to this survey, the treatment of GBS in Italy tends only partly to reflect the indications and recommendations in the main scientific reports. This not only indicates a suboptimal impact of the best available knowledge on the treatment of GBS, but also documents the need for more definite guidelines and further research through clinical trials.",
keywords = "Acute polyneuritis, Audit, Guillain-Barre syndrome, Immunoglobulins, Pharmacoepidemiology, Plasma exchange, Steroids, Therapy",
author = "E. Beghi and A. Bono and G. Bogliun and F. Cornelio and N. Rizzuto and P. Tonali and D. Zerbi and C. Castelli and G. Ferrari and M. Marconi and P. Simone and F. Apollo and L. Amoruso and C. Angelini and C. Briani and E. Fincati and R. Affuso and E. Bottacchi and C. Lia",
year = "1995",
doi = "10.1002/pds.2630040306",
language = "English",
volume = "4",
pages = "137--146",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Audit of care of acute inflammatory polyradiculoneuropathy in Italy

AU - Beghi, E.

AU - Bono, A.

AU - Bogliun, G.

AU - Cornelio, F.

AU - Rizzuto, N.

AU - Tonali, P.

AU - Zerbi, D.

AU - Castelli, C.

AU - Ferrari, G.

AU - Marconi, M.

AU - Simone, P.

AU - Apollo, F.

AU - Amoruso, L.

AU - Angelini, C.

AU - Briani, C.

AU - Fincati, E.

AU - Affuso, R.

AU - Bottacchi, E.

AU - Lia, C.

PY - 1995

Y1 - 1995

N2 - A multicentre prospective investigation of the main treatment regimens for the Guillain-Barre syndrome (GBS) was started in Italy to assess the quality of the care delivered for GBS in clinical practice. Between 14 April 1988 and 31 December 1993, 250 patients (157 males and 93 females aged 3 to 86 years) were recruited in 14 centres. The commonest treatments were plasma exchange (PE) (62 per cent), steroids (ST) (37 per cent) and immunoglobulins (IG) (19 per cent). Eighteen per cent of cases received ST and PE. These data contrast in part with reports on the treatment of GBS published between 1976 and 1993, which showed PE as an effective treatment, IG as a promising but still experimental drug, and ST as a failing therapeutic approach. The variables which seemed to affect the treatment choices most were centre, year of diagnosis, and disease severity. According to this survey, the treatment of GBS in Italy tends only partly to reflect the indications and recommendations in the main scientific reports. This not only indicates a suboptimal impact of the best available knowledge on the treatment of GBS, but also documents the need for more definite guidelines and further research through clinical trials.

AB - A multicentre prospective investigation of the main treatment regimens for the Guillain-Barre syndrome (GBS) was started in Italy to assess the quality of the care delivered for GBS in clinical practice. Between 14 April 1988 and 31 December 1993, 250 patients (157 males and 93 females aged 3 to 86 years) were recruited in 14 centres. The commonest treatments were plasma exchange (PE) (62 per cent), steroids (ST) (37 per cent) and immunoglobulins (IG) (19 per cent). Eighteen per cent of cases received ST and PE. These data contrast in part with reports on the treatment of GBS published between 1976 and 1993, which showed PE as an effective treatment, IG as a promising but still experimental drug, and ST as a failing therapeutic approach. The variables which seemed to affect the treatment choices most were centre, year of diagnosis, and disease severity. According to this survey, the treatment of GBS in Italy tends only partly to reflect the indications and recommendations in the main scientific reports. This not only indicates a suboptimal impact of the best available knowledge on the treatment of GBS, but also documents the need for more definite guidelines and further research through clinical trials.

KW - Acute polyneuritis

KW - Audit

KW - Guillain-Barre syndrome

KW - Immunoglobulins

KW - Pharmacoepidemiology

KW - Plasma exchange

KW - Steroids

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0029126236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029126236&partnerID=8YFLogxK

U2 - 10.1002/pds.2630040306

DO - 10.1002/pds.2630040306

M3 - Article

AN - SCOPUS:0029126236

VL - 4

SP - 137

EP - 146

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 3

ER -